Cellosaurus LO-CD2a (CVCL_A6CS)
Cell line name | LO-CD2a |
---|---|
Synonyms | LO-CD2A; Lo-CD2a; LO-CD2-act; Lo-CD2-act; BTI-322 |
Accession | CVCL_A6CS |
Resource Identification Initiative | To cite this cell line use: LO-CD2a (RRID:CVCL_A6CS) |
Comments | Group: Patented cell line. Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11423. Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized siplizumab (MEDI-507) therapeutic antibody. Monoclonal antibody isotype: IgG2b, kappa. Monoclonal antibody target: UniProtKB; P06729; Human CD2. |
Species of origin | Rattus norvegicus (Rat) (NCBI Taxonomy: 10116) |
Hierarchy | Parent: CVCL_7675 (IR983F) |
Category | Hybridoma |
Publications | CLPUB00617 PubMed=7627995; DOI=10.1007/BF01525389; PMCID=PMC11037751 PubMed=8757956; DOI=10.1093/intimm/8.7.1113 Patent=US6849258 Patent=US7592006 |
Cross-references | |
Cell line collections (Providers) | ATCC; CRL-3535 |
Biological sample resources | ABCD; ABCD_AH427 |
Encyclopedic resources | Wikidata; Q107115673 |
Entry history | |
Entry creation | 20-May-2021 |
Last entry update | 02-May-2024 |
Version number | 5 |